Article Data

  • Views 624
  • Dowloads 124

Original Research

Open Access

Terlipressin/adrenaline is better than adrenaline alone in a porcine model of prolonged ventricular fibrillation

A randomized controlled study


1Department of Anaesthesiology and Intensive Care, Charles University in Prague, Faculty of Medicine in Hradec Kralove, University Hospital Hradec Kralove

2Department of Anaesthesiology and Intensive Care, Charles University in Prague, Faculty of Medicine in Hradec Kralove, University Hospital Hradec Kralove

3Emergency Medical Services of the Central Bohemian Region, Beroun, Czech Republic /Department of Anaesthesiology and Intensive Care, Charles University in Prague, Faculty of Medicine in Hradec Kralove, University Hospital Hradec Kralove

4Department of Anesthesia, Dalhousie University

5Department of Anaesthesiology and Intensive Care Medicine, Ernst Moritz Arndt University

6Department of Anaesthesiology and Intensive Care, Charles University in Prague, Faculty of Medicine in Hradec Kralove, University Hospital Hradec Kralove, Czech Republic /Department of Anesthesia, Dalhousie University

DOI: 10.22514/SV71.042012.2 Vol.7,Issue 1,April 2012 pp.10-16

Published: 30 April 2012

*Corresponding Author(s): ANATOLIJ TRUHLAR E-mail:


Objectives. Vasopressors have been routinely used in cardiopulmonary resuscitation. Recent data show that terlipressin may restore blood pressure in asphyxial and prolonged arrests but its potential role in ventricular fibrillation (VF) remains unknown. The aim of this study was to compare coronary (CorPP) and cerebral (CPP) perfusion pressures achieved by terlipressin/adrenaline versus placebo/adrenaline in VF.

Methods. Fourteen domestic pigs were randomly assigned into group A and B. After 5 min of untreated VF, compression-only resuscitation was applied for 10 min, followed by advanced life support. Terlipressin in a single-dose of 30 􀀁g·kg-1 was added to the first dose of adrenaline in group A, while placebo was given in group B. CorPP and CPP were calcula-ted from right atrial, aortic and intracerebral pressures. Data were analyzed using repeated measurements ANOVA and a Fisher´s protected LSD post hoc test.

Results. Terlipressin/adrenaline maintained CorPP above 10 mmHg for 17.7 min longer than adrenaline alone (P=0.003) unable to prevent refractory hypotension. CorPP (mean±SD) measured at 35, 45, and 55 min after the onset of VF was 12 ± 4, 11 ± 6, and 10 ± 5 mmHg in the terlipressin group A; and 6 ± 4, 1 ± 5, and -1 ± 5 mmHg in placebo group B (P=0.03, <0.001, and <0.001). CPP measured at the same times was 23 ± 7, 20 ± 7, and 23 ± 7 mmHg in group A; and 13 ± 7, 6 ± 5, and 6 ± 7 mmHg in group B (P=0.01, <0.001, and <0.001).

Conclusion. The study showed that a single dose of terlipressin, when added to adrenaline, was effective for achievement of higher vital organ perfusion pressures compared to adrenaline alone.


cardiopulmonary resusci-tation (CPR), cardiac arrest, terlipre-ssin, vasopressor therapy, cerebral perfusion pressure, coronary perfu-sion pressure, ventricular fibrillation

Cite and Share

ANATOLIJ TRUHLAR,ZDENEK TUREK,ROMAN SKULEC,CHRISTIAN LEHMANN ,DRAGAN PAVLOVIC,VLADIMIR CERNY. Terlipressin/adrenaline is better than adrenaline alone in a porcine model of prolonged ventricular fibrillationA randomized controlled study. Signa Vitae. 2012. 7(1);10-16.


1. Gazmuri RJ, Correa BM. Cardiovascular Function and Vascular Tone: Physiology for ECC. In: Field JM, editor. The Textbook of Emergency Cardio-vascular Care and CPR, 1st ed. Philadelphia: Lippincott Williams & Wilkins; 2009. p. 395-409.

2. Paradis NA, Martin GB, Rivers EP, Goetting MG, Appleton TJ, Feingold M, et al. Coronary perfusion pressure and the return of spontaneous circu-lation in human cardiopulmonary resuscitation. JAMA 1990;263:1106-13.

3. Ebmeyer U, Katz LM, Guerci AD. Methods to improve cerebral blood flow and neurological outcome after cardiac arrest. In: Cardiac arrest. The science and practice of resuscitation medicine. 2nd ed. New York: Cambridge University Press; 2007. p. 389-94.

4. Safar P. Community-wide cardiopulmonary resuscitation. J Iowa Med Soc 1964;54:629-35.

5. Deakin CD, Nolan JP, Soar J, Sunde K, Koster RW, Smith GB, et al. European Resuscitation Council guidelines for resuscitation 2010. Section 4. Adult advanced life support. Resuscitation 2010;81:1305-52.

6. Neumar RW, Otto CW, Link MS, Kronick SL, Shuster M, Callaway CW, et al. Part 8: Adult Advanced Cardiovascular Life Support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010;122:S640-56.

7. Lindner KH, Dirks B, Strohmenger HU, Prengel AW, Lindner AW, Lurie KG. A randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation. Lancet 1997;347:535-7.

8. Wenzel V, Krismer AC, Arntz HR, Sitter H, Stadlbauer KH, Lindner KH. A comparison of vasopressin and epinephrine for out-of-hospital cardiopul-monary resuscitation. N Engl J Med 2004;350:105-13.

9. Gueugniaud PY, David JS, Chanzy E, Hubert H, Dubien PY, Mauriaucourt P, et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopul-monary resuscitation. N Engl J Med 2008;359:21-30.

10. Li X, Jing XL, Li H, Liao XX, Xiong Y, Wang XF. Vasopressin and epinephrine versus epinephrine in management of patients with cardiac arrest: a meta-analysis. Signa Vitae 2010;5:20-6.

11. Leone M. Terlipressin or Europressin? Crit Care 2009;13:192.

12. Zuidema X, Dünser MW, Wenzel V, Rozendaal FW, de Jager CP. Terlipressin as an adjunct vasopressor in refractory hypotension after tricyclic antidepressant intoxication. Resuscitation 2007;72:319-23.

13. Rocq N, Favier JC, Plancade D, Steiner T, Mertes PM. Successful use of terlipressin in post-cardiac arrest resuscitation after an epinephrine-resistant anaphylactic shock to suxamethonium. Anesthesiology 2007;107:166-7.

14. Matok I, Vardi A, Augarten A, Efrati O, Leibovitch L, Rubinshtein M, et al. Beneficial effects of terlipressin in prolonged pediatric cardiopulmonary resuscitation: a case series. Crit Care Med 2007;35:1161-4.

15. López-Herce J, Gil-Antón J, Morteruel E, Carrillo A, Rodríguez-Núñez A. Terlipressin for paediatric cardiac arrest refractory to advanced resuscitation. Resuscitation 2008;77:S32.

16. Fernández B, Mencía S, López-Herce J, Sánchez C, Urbano J, Rodríguez-Núñez A. Resuscitation from post-asphyxial cardiac arrest with adrenaline and terlipressin in a paediatric animal model. Resuscitation 2008;77:S32.

17. Gil-Antón J, López-Herce J, Morteruel E, Carrillo A, Rodríguez-Núñez A. Pediatric cardiac arrest refractory to advanced life support: Is there a role for terlipressin? Pediatr Crit Care Med 2010;11:139-41.

18. Kam PCA, Williams S, Yoong FFY. Vasopressin and terlipressin: pharmacology and its clinical relevance. Anaesthesia 2004;59:993-1001.

19. Kaiser GM, Frühauf NR. Method of intracranial pressure monitoring and cerebrospinal fluid sampling in swine. Lab Anim 2007;41:80-5.

20. Bricker S. (Raised) Intracranial pressure. In: Bricker S. The Anaesthesia Science Viva Book, 2nd ed. Cambridge: Cambridge University Press; 2005. 

p. 124-8.

21. Krep H, Mamier M, Breil M, Heister U, Fischer M, Hoeft A. Out-of-hospital cardiopulmonary resuscitation with the AutoPulse system: A prospective observational study with a new load-distributing band chest compression device. Resuscitation 2007;73:86-95.

22. Olasveengen TM, Wik L, Steen PA. Quality of cardiopulmonary resuscitation before and during transport in out-of-hospital cardiac arrest. Resusci-tation 2008;76:185–90.

23. Niemann JT, Criley JM, Rosborough JP. Predictive indices of successful cardiac resuscitation after prolonged arrest and experimental cardiopul-monary resuscitation. Ann Emerg Med 1985;14:521–8.

24. Gazmuri RJ, Berkowitz M, Cajigas H. Myocardial effects of ventricular fibrillation in the isolated rat heart. Crit Care Med 1999;27:1542-50.

25. Olasveengen TM, Sunde K, Brunborg C, Thowsen J, Steen PA, Wik L. Intravenous drug administration during out-of-hospital cardiac arrest: a ran-domized trial. JAMA 2009;302:2222-9.

26. Spöhr F, Wenzel V, Böttiger BW. Thrombolysis and other drugs during cardiopulmonary resuscitation. Curr Opin Crit Care 2008;14:292-8.

27. Reynolds JC, Rittenberger JC, Menegazzi JJ. Drug administration in animal studies of cardiac arrest does not reflect human clinical experience. Resuscitation 2007;74:13-26.

28. Mader TJ. Prolonged cardiac arrest: a revised model of porcine ventricular fibrillation. Resuscitation 2008;76:481-4.

29. Sayre MR, Berg RA, Cave DM, Page RL, Potts J, White RD; American Heart Association Emergency Cardiovascular Care Committee. Hands-only (compression-only) cardiopulmonary resuscitation: a call to action for bystander response to adults who experience out-of-hospital sudden cardiac arrest: a science advisory for the public from the American Heart Association Emergency Cardiovascular Care Committee. Circulation 2008;117:2162-7.

30. Meybohm P, Cavus E, Dörges V, Steinfath M, Sibbert L, Wenzel V, et al. Revised resuscitation guidelines: adrenaline versus adrenaline/vasopressin in a pig model of cardiopulmonary resuscitation--a randomised, controlled trial. Resuscitation 2007;75:380-8.

31. Weisfeldt ML, Becker LB. Resuscitation after cardiac arrest: a 3-phase time-sensitive model. JAMA 2002;288:3035-8.

32. Kern KB, Halperin HR, Field JR. New guidelines for cardiopulmonary resuscitation and emergency cardiac care: changes in the management of cardiac arrest. JAMA 2001;285:1267-9.

33. Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Cecchini V, et al. Continuous terlipressin versus vasopressin infusion in septic shock (TER-LIVAP): a randomized, controlled pilot study. Crit Care 2009;13:R130.

34. Delmas A, Leone M, Rousseau S, Albanèse J, Martin C. Clinical review: Vasopressin and terlipressin in septic shock patients. Crit Care 2005;9:212-22.

35. Ryckwaert F, Virsolvy A, Fort A, Murat B, Richard S, Guillon G, Colson P. Terlipressin, a provasopressin drug exhibits direct vasoconstrictor proper-ties: consequences on heart perfusion and performance. Crit Care Med 2009;37:876-81.

36. Fries M, Tang W, Chang YT, Wang J, Castillo C, Weil MH. Microvascular blood flow during cardiopulmonary resuscitation is predictive of outcome. Resuscitation 2006;71:248-53.

37. Halperin HR, Paradis N, Ornato JP, Zviman M, Lacorte J, Lardo A, et al. Cardiopulmonary resuscitation with a novel chest compression device in a porcine model of cardiac arrest: improved hemodynamics and mechanisms. J Am Coll Cardiol 2004;44:2214-20.

38. Sharff JA, Pantley G, Noel E. Effect of time on regional organ perfusion during two methods of cardiopulmonary resuscitation. Ann Emerg Med 1984;13:649-56.

39. Ioannou G, Doust J, Rockey DC. Terlipressin for acute esophageal variceal hemorrhage. Cochrane Database Syst Rev 2003;1:CD002147.

40. O'Brien A, Clapp L, Singer M. Terlipressin for norepinephrine-resistant septic shock. Lancet 2002;359:1209-10.

41. Leone M, Albanèse J, Delmas A, Chaabane W, Garnier F, Martin C. Terlipressin in catecholamine-resistant septic shock patients. Shock 2004;22:314-9.

42. Papoff P, Mancuso M, Barbara CS, Moretti C. The role of terlipressin in pediatric septic shock: a review of the literature and personal experience. Int J Immunopathol Pharmacol 2007;20:213-21.

43. Rodríguez-Núñez A, López-Herce J, Gil-Antón J, Hernández A, Rey C; RETSPED Working Group of the Spanish Society of Pediatric Intensive Care. Rescue treatment with terlipressin in children with refractory septic shock: a clinical study. Crit Care 2006;10:R20.

44. Asfar P, Radermacher P. Vasopressin and ischaemic heart disease: more than coronary vasoconstriction? Crit Care 2009;13:169.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

IndexCopernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 0.5(2019) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time